[1]
R. Sahai, T. Sharma, D. C. Dhasmana, and N. Kaeley, “Comparative efficacy and safety of DPP-4 inhibitors and α-glucosidase inhibitors as add on therapy in type 2 diabetes”, Int J Basic Clin Pharmacol, vol. 7, no. 4, pp. 707–713, Mar. 2018.